drug · antibody
patient view →infliximab biosimilar
Marketedupdated 2mo agoby Xentria Inc🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 44 investigational indications.
indications
investigational
IBD (Crohn's + UC)Rheumatoid Arthritis
targets
Tumor necrosis factor
all catalysts(6)
approval · 6
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that